Intrinsic value of Xylem - XYL

Previous Close

$51.41

  Intrinsic Value

premium content

  Rating & Target

premium content

  Value-price divergence*

premium content

Previous close

$51.41

 
Intrinsic value

$40.32

 
Up/down potential

-22%

 
Rating

sell

 
Value-price divergence* premium content

Premium access subscription - $499/yr

please register and log in before paying

*Intrinsic value change (in %) minus stock price change (in %) in the past 12 months.

We calculate the intrinsic value of XYL stock by summing up the current values of future distributable cash flows generated by the company and dividing the sum by the number of outstanding shares. As such, the intrinsic value calculation depends entirely on projections. The more accurate your projections of the company's performance are - the more reliable is the intrinsic value calculation result. Please make sure to check the stock valuation input data below and adjust it if necessary. The quality of the output (intrinsic valuation result) is only as good as the quality of the input. See also DISCLAIMERS.

STOCK VALUATION INPUT DATA

Revenue (in 2016), $M
Initial revenue growth rate, %
Terminal revenue growth rate, %
Revenue decline factor
Initial discount rate, %
Discount rate multiplier
Variable cost ratio, %
Fixed operating expenses, $M
Interest rate on debt, %
Effective corporate tax rate, %
Production assets / Revenue, %
Life of production assets, yrs
Working capital / Revenue, %
Revenue / Adjusted assets
Adjusted equity ratio
Cash flow adjustment, % of Revenue
Book value of equity, $M
Shares outstanding, mln
Market capitalization, $bln 9.3

 

FINANCIAL STATEMENTS FORECAST and PRESENT VALUE CALCULATION

Fiscal year
2016(a)
   2017
   2018
   2019
   2020
   2021
   2022
   2023
   2024
   2025
   2026
   2027
   2028
   2029
   2030
   2031
   2032
   2033
   2034
   2035
   2036
   2037
   2038
   2039
   2040
   2041
   2042
   2043
   2044
   2045
   2046

INCOME STATEMENT

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Revenue growth rate, %
  3.23
  10.20
  9.68
  9.21
  8.79
  8.41
  8.07
  7.76
  7.49
  7.24
  7.01
  6.81
  6.63
  6.47
  6.32
  6.19
  6.07
  5.96
  5.87
  5.78
  5.70
  5.63
  5.57
  5.51
  5.46
  5.41
  5.37
  5.34
  5.30
  5.27
  5.24
Revenue, $m
  3,771
  4,156
  4,558
  4,978
  5,415
  5,871
  6,345
  6,837
  7,349
  7,881
  8,434
  9,009
  9,606
  10,227
  10,874
  11,547
  12,248
  12,978
  13,740
  14,534
  15,363
  16,228
  17,132
  18,076
  19,063
  20,096
  21,175
  22,305
  23,488
  24,726
  26,023
Variable operating expenses, $m
 
  3,609
  3,933
  4,271
  4,624
  4,990
  5,372
  5,769
  6,181
  6,609
  7,054
  7,254
  7,735
  8,235
  8,756
  9,298
  9,862
  10,450
  11,063
  11,703
  12,370
  13,067
  13,795
  14,555
  15,350
  16,181
  17,051
  17,960
  18,913
  19,910
  20,954
Fixed operating expenses, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total operating expenses, $m
  3,365
  3,609
  3,933
  4,271
  4,624
  4,990
  5,372
  5,769
  6,181
  6,609
  7,054
  7,254
  7,735
  8,235
  8,756
  9,298
  9,862
  10,450
  11,063
  11,703
  12,370
  13,067
  13,795
  14,555
  15,350
  16,181
  17,051
  17,960
  18,913
  19,910
  20,954
Operating income, $m
  406
  546
  625
  706
  792
  880
  973
  1,069
  1,168
  1,272
  1,380
  1,755
  1,871
  1,992
  2,118
  2,249
  2,386
  2,528
  2,676
  2,831
  2,993
  3,161
  3,337
  3,521
  3,713
  3,915
  4,125
  4,345
  4,575
  4,817
  5,069
EBITDA, $m
  557
  874
  959
  1,047
  1,139
  1,235
  1,335
  1,438
  1,546
  1,658
  1,774
  1,895
  2,021
  2,152
  2,288
  2,429
  2,577
  2,730
  2,891
  3,058
  3,232
  3,414
  3,604
  3,803
  4,011
  4,228
  4,455
  4,693
  4,942
  5,202
  5,475
Interest expense (income), $m
  49
  74
  88
  103
  119
  135
  152
  170
  188
  207
  227
  248
  269
  292
  315
  339
  364
  390
  418
  446
  476
  507
  539
  573
  608
  645
  683
  724
  766
  810
  856
Earnings before tax, $m
  340
  473
  537
  603
  673
  745
  821
  899
  980
  1,065
  1,152
  1,507
  1,602
  1,701
  1,803
  1,910
  2,022
  2,138
  2,259
  2,385
  2,517
  2,655
  2,798
  2,948
  3,105
  3,270
  3,441
  3,621
  3,809
  4,007
  4,213
Tax expense, $m
  80
  128
  145
  163
  182
  201
  222
  243
  265
  287
  311
  407
  433
  459
  487
  516
  546
  577
  610
  644
  680
  717
  756
  796
  838
  883
  929
  978
  1,029
  1,082
  1,137
Net income, $m
  260
  345
  392
  440
  491
  544
  599
  656
  715
  777
  841
  1,100
  1,169
  1,241
  1,316
  1,395
  1,476
  1,561
  1,649
  1,741
  1,837
  1,938
  2,043
  2,152
  2,267
  2,387
  2,512
  2,644
  2,781
  2,925
  3,075

BALANCE SHEET

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Cash and short-term investments, $m
  308
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Total assets, $m
  6,474
  6,790
  7,448
  8,134
  8,849
  9,593
  10,367
  11,172
  12,008
  12,878
  13,781
  14,720
  15,696
  16,711
  17,768
  18,868
  20,013
  21,207
  22,451
  23,749
  25,103
  26,517
  27,993
  29,536
  31,149
  32,836
  34,600
  36,447
  38,379
  40,403
  42,522
Adjusted assets (=assets-cash), $m
  6,166
  6,790
  7,448
  8,134
  8,849
  9,593
  10,367
  11,172
  12,008
  12,878
  13,781
  14,720
  15,696
  16,711
  17,768
  18,868
  20,013
  21,207
  22,451
  23,749
  25,103
  26,517
  27,993
  29,536
  31,149
  32,836
  34,600
  36,447
  38,379
  40,403
  42,522
Revenue / Adjusted assets
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
  0.612
Average production assets, $m
  1,346
  1,484
  1,627
  1,777
  1,933
  2,096
  2,265
  2,441
  2,624
  2,814
  3,011
  3,216
  3,429
  3,651
  3,882
  4,122
  4,373
  4,633
  4,905
  5,189
  5,485
  5,793
  6,116
  6,453
  6,806
  7,174
  7,560
  7,963
  8,385
  8,827
  9,290
Working capital, $m
  601
  611
  670
  732
  796
  863
  933
  1,005
  1,080
  1,159
  1,240
  1,324
  1,412
  1,503
  1,598
  1,697
  1,800
  1,908
  2,020
  2,137
  2,258
  2,386
  2,518
  2,657
  2,802
  2,954
  3,113
  3,279
  3,453
  3,635
  3,825
Total debt, $m
  2,368
  2,518
  2,947
  3,395
  3,862
  4,348
  4,854
  5,379
  5,926
  6,493
  7,083
  7,696
  8,334
  8,997
  9,686
  10,405
  11,153
  11,932
  12,744
  13,592
  14,476
  15,399
  16,364
  17,371
  18,425
  19,526
  20,678
  21,884
  23,146
  24,467
  25,851
Total liabilities, $m
  4,284
  4,434
  4,863
  5,311
  5,778
  6,264
  6,770
  7,295
  7,842
  8,409
  8,999
  9,612
  10,250
  10,913
  11,602
  12,321
  13,069
  13,848
  14,660
  15,508
  16,392
  17,315
  18,280
  19,287
  20,341
  21,442
  22,594
  23,800
  25,062
  26,383
  27,767
Total equity, $m
  2,190
  2,356
  2,584
  2,822
  3,070
  3,329
  3,597
  3,877
  4,167
  4,469
  4,782
  5,108
  5,447
  5,799
  6,165
  6,547
  6,945
  7,359
  7,790
  8,241
  8,711
  9,201
  9,714
  10,249
  10,809
  11,394
  12,006
  12,647
  13,318
  14,020
  14,755
Total liabilities and equity, $m
  6,474
  6,790
  7,447
  8,133
  8,848
  9,593
  10,367
  11,172
  12,009
  12,878
  13,781
  14,720
  15,697
  16,712
  17,767
  18,868
  20,014
  21,207
  22,450
  23,749
  25,103
  26,516
  27,994
  29,536
  31,150
  32,836
  34,600
  36,447
  38,380
  40,403
  42,522
Debt-to-equity ratio
  1.081
  1.070
  1.140
  1.200
  1.260
  1.310
  1.350
  1.390
  1.420
  1.450
  1.480
  1.510
  1.530
  1.550
  1.570
  1.590
  1.610
  1.620
  1.640
  1.650
  1.660
  1.670
  1.680
  1.690
  1.700
  1.710
  1.720
  1.730
  1.740
  1.750
  1.750
Adjusted equity ratio
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347
  0.347

CASH FLOW

 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Net income, $m
  260
  345
  392
  440
  491
  544
  599
  656
  715
  777
  841
  1,100
  1,169
  1,241
  1,316
  1,395
  1,476
  1,561
  1,649
  1,741
  1,837
  1,938
  2,043
  2,152
  2,267
  2,387
  2,512
  2,644
  2,781
  2,925
  3,075
Depreciation, amort., depletion, $m
  151
  328
  334
  341
  348
  355
  362
  370
  378
  386
  395
  140
  150
  159
  170
  180
  191
  202
  214
  227
  240
  253
  267
  282
  297
  313
  330
  348
  366
  385
  406
Funds from operations, $m
  558
  673
  726
  781
  839
  899
  961
  1,026
  1,093
  1,163
  1,236
  1,241
  1,319
  1,401
  1,486
  1,575
  1,667
  1,763
  1,863
  1,968
  2,077
  2,191
  2,310
  2,434
  2,564
  2,700
  2,842
  2,991
  3,147
  3,310
  3,481
Change in working capital, $m
  61
  57
  59
  62
  64
  67
  70
  72
  75
  78
  81
  84
  88
  91
  95
  99
  103
  107
  112
  117
  122
  127
  133
  139
  145
  152
  159
  166
  174
  182
  191
Cash from operations, $m
  497
  1,088
  667
  719
  774
  832
  891
  953
  1,018
  1,085
  1,155
  1,156
  1,231
  1,310
  1,391
  1,476
  1,564
  1,656
  1,751
  1,851
  1,955
  2,064
  2,177
  2,295
  2,419
  2,548
  2,684
  2,825
  2,973
  3,128
  3,290
Maintenance CAPEX, $m
  0
  -59
  -65
  -71
  -78
  -84
  -92
  -99
  -107
  -115
  -123
  -131
  -140
  -150
  -159
  -170
  -180
  -191
  -202
  -214
  -227
  -240
  -253
  -267
  -282
  -297
  -313
  -330
  -348
  -366
  -385
New CAPEX, $m
  -124
  -138
  -144
  -150
  -156
  -163
  -169
  -176
  -183
  -190
  -197
  -205
  -213
  -222
  -231
  -240
  -250
  -261
  -272
  -284
  -296
  -309
  -323
  -337
  -352
  -369
  -385
  -403
  -422
  -442
  -463
Cash from investing activities, $m
  -1,886
  -197
  -209
  -221
  -234
  -247
  -261
  -275
  -290
  -305
  -320
  -336
  -353
  -372
  -390
  -410
  -430
  -452
  -474
  -498
  -523
  -549
  -576
  -604
  -634
  -666
  -698
  -733
  -770
  -808
  -848
Free cash flow, $m
  -1,389
  891
  458
  499
  541
  585
  631
  679
  729
  781
  834
  819
  878
  938
  1,001
  1,066
  1,133
  1,204
  1,277
  1,353
  1,433
  1,515
  1,601
  1,691
  1,785
  1,883
  1,985
  2,092
  2,203
  2,320
  2,442
Issuance/(repayment) of debt, $m
  1,126
  410
  429
  448
  467
  486
  506
  526
  546
  568
  590
  613
  637
  663
  690
  718
  748
  779
  812
  847
  884
  923
  964
  1,008
  1,053
  1,101
  1,152
  1,206
  1,262
  1,321
  1,384
Issuance/(repurchase) of shares, $m
  20
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash from financing (excl. dividends), $m  
  1,146
  410
  429
  448
  467
  486
  506
  526
  546
  568
  590
  613
  637
  663
  690
  718
  748
  779
  812
  847
  884
  923
  964
  1,008
  1,053
  1,101
  1,152
  1,206
  1,262
  1,321
  1,384
Total cash flow (excl. dividends), $m
  -260
  1,301
  888
  947
  1,008
  1,071
  1,136
  1,204
  1,275
  1,348
  1,424
  1,433
  1,515
  1,601
  1,691
  1,784
  1,881
  1,983
  2,090
  2,201
  2,317
  2,438
  2,566
  2,699
  2,838
  2,984
  3,137
  3,297
  3,465
  3,641
  3,826
Retained Cash Flow (-), $m
  -106
  -214
  -228
  -238
  -248
  -258
  -269
  -279
  -290
  -302
  -313
  -326
  -339
  -352
  -367
  -382
  -397
  -414
  -432
  -450
  -470
  -491
  -512
  -535
  -560
  -585
  -612
  -641
  -671
  -702
  -735
Prev. year cash balance distribution, $m
 
  48
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash flow adjustment, $m
 
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
  0
Cash available for distribution, $m
 
  1,135
  660
  708
  759
  813
  868
  925
  985
  1,047
  1,111
  1,107
  1,176
  1,249
  1,324
  1,402
  1,484
  1,569
  1,658
  1,750
  1,847
  1,948
  2,053
  2,163
  2,278
  2,399
  2,525
  2,657
  2,795
  2,939
  3,090
Discount rate, %
 
  7.50
  7.88
  8.27
  8.68
  9.12
  9.57
  10.05
  10.55
  11.08
  11.63
  12.22
  12.83
  13.47
  14.14
  14.85
  15.59
  16.37
  17.19
  18.05
  18.95
  19.90
  20.89
  21.94
  23.04
  24.19
  25.40
  26.67
  28.00
  29.40
  30.87
PV of cash for distribution, $m
 
  1,056
  567
  558
  544
  525
  501
  473
  441
  406
  370
  311
  276
  242
  208
  176
  146
  119
  95
  75
  57
  43
  32
  23
  16
  11
  7
  4
  3
  2
  1
Current shareholders' claim on cash, %
  100
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0
  100.0

Xylem Inc. engages in the design, manufacture, and service of engineered solutions for the water and wastewater applications. It operates through three segments: Water Infrastructure, Applied Water, and Sensus. The Water Infrastructure segment offers various products, including water and wastewater pumps, treatment and testing equipment, and controls and systems, as well as filtration, disinfection, and biological treatment equipment under the Flygt, WEDECO, Godwin, WTW, Sanitaire, YSI, and Leopold names for the transportation, treatment, and testing of water and wastewater for public utilities and industrial applications. The Applied Water segment provides pumps, valves, heat exchangers, controls, and dispensing equipment systems under the Goulds Water Technology, Bell & Gossett, A-C Fire Pump, Standard Xchange, Lowara, Jabsco, Flojet, and Flowtronex names for residential and commercial building services, industrial water, and irrigation applications. The Sensus segment provides communications, smart metering, measurement, and control technologies and services that allow customers to use their distribution networks for the delivery of critical resources, such as water, electricity, and natural gas. This segment also offers software and services, including cloud-based analytics, remote monitoring, and data management, as well as sells smart lighting products and solutions. The company markets and sells its products through a network of direct sales force, resellers, distributors, and value-added solution providers in the United States, Europe, the Asia Pacific, and internationally. Xylem Inc. is headquartered in Rye Brook, New York.

FINANCIAL RATIOS  of  Xylem (XYL)

Valuation Ratios
P/E Ratio 35.5
Price to Sales 2.4
Price to Book 4.2
Price to Tangible Book
Price to Cash Flow 18.6
Price to Free Cash Flow 24.7
Growth Rates
Sales Growth Rate 3.2%
Sales - 3 Yr. Growth Rate %
EPS Growth Rate %
EPS - 3 Yr. Growth Rate %
Capital Spending Gr. Rate 6%
Cap. Spend. - 3 Yr. Gr. Rate -0.3%
Financial Strength
Quick Ratio 1
Current Ratio 0
LT Debt to Equity 96.3%
Total Debt to Equity 108.1%
Interest Coverage 8
Management Effectiveness
Return On Assets 5.3%
Ret/ On Assets - 3 Yr. Avg. 7.1%
Return On Total Capital 6.6%
Ret/ On T. Cap. - 3 Yr. Avg. 8.8%
Return On Equity 12.2%
Return On Equity - 3 Yr. Avg. 14.6%
Asset Turnover 0.7
Profitability Ratios
Gross Margin 38.7%
Gross Margin - 3 Yr. Avg. 38.6%
EBITDA Margin 14.3%
EBITDA Margin - 3 Yr. Avg. 15.4%
Operating Margin 10.8%
Oper. Margin - 3 Yr. Avg. 11.8%
Pre-Tax Margin 9%
Pre-Tax Margin - 3 Yr. Avg. 10.3%
Net Profit Margin 6.9%
Net Profit Margin - 3 Yr. Avg. 8.3%
Effective Tax Rate 23.5%
Eff/ Tax Rate - 3 Yr. Avg. 19.7%
Payout Ratio 43.1%

XYL stock valuation input parameters

Revenue. Company's revenue (or sales) is always the starting point of any cash flow forecast. In the XYL stock intrinsic value calculation we used $3771 million for the last fiscal year's total revenue generated by Xylem. The default revenue input number comes from 2016 income statement of Xylem. You may change it if you feel that it should be adjusted for some unusual circumstances that are not expected to be repeated in the future or if you already know (from interim financial statements, for example) that this year's revenue is going to be quite different.

Revenue growth rate. Forecasted future revenue growth rate is the most important input parameter for the intrinsic value calculation. Unlike other input parameters that are reasonably expected to be in line with their historic averages or their historic trends, the revenue growth rate by and large is a wild card: nobody really knows what the company's revenue will be in the future. Of course, the level of unpredictability is different for different industries (utility companies being the most predictable and, thus, less risky).
    We use three input parameters to forecast the revenue growth rate in our XYL stock valuation model: a) initial revenue growth rate of 10.2% whose default value is the revenue growth rate in the most recent quarter compared to the quarterly revenue a year ago; b) terminal revenue growth rate of 5% whose default value is chosen to be close to the average nominal (i.e. not adjusted for inflation) GDP growth rate; and c) revenue decline factor of 0.9, which stipulates that revenue growth rate in each forecasted year will be equal to the difference of the revenue growth rate in the preceding year and the terminal revenue growth rate multiplied by this revenue decline factor (with the passage of time the revenue growth rate will be approaching the terminal revenue growth rate, but not quite reaching it - though the difference could be infinitesimally small).
    At the revenue decline factor of 1, the future revenue growth rate is forecasted to be constant and equal to the initial revenue growth rate. The smaller the revenue decline factor, the faster the revenue growth rate will approach the terminal revenue growth.

Discount rate. The discount rate is used for determining the present value of future cash flows: future cash flows are "discounted" as at normal conditions (that translate into positive expected return on investment) one dollar today is worth more than the same dollar in the future. Unlike all other valuation models, we use variable discount rate, i.e. it increases for each consecutive year. This is done to account for higher risk of cash flows coming in further in the future.
    The initial discount rate of 7.5%, whose default value for XYL is calculated based on our internal credit rating of Xylem, is applied to the cash flow expected to be received a year from now (well, actually, to be precise, in the financial year following the base year - the last year for which we have financial statements). For each consecutive year the discount rate is multiplied by the discount rate multiplier of 1.05, e.i. each year it increases by 5%. Feel free to change this number to correspond to your level of risk assessment of Xylem.
    By the way, it is easy to set the discount rate to be constant (this would make comparison with other valuation models easier): just set the discount rate multiplier equal to 1 and chose the magnitude of the initial discount rate to your liking.

Variable cost ratio is the ratio of variable costs (i.e. costs that fluctuate with fluctuation of the volume of production) to the revenue expressed as a percentage. In the calculation of intrinsic value of XYL stock the variable cost ratio is equal to 87.5%.

Fixed operating expenses is just that - expenses that are not dependant on the volume of production. They are set to $0 million in the base year in the intrinsic value calculation for XYL stock. These expenses increase with the level of inflation in subsequent years.

Interest rate on debt is the average all-in rate of interest paid by the company on its debt. It is set at 3.5% for Xylem.

Corporate tax rate of 27% is the nominal tax rate for Xylem. In reality, companies find ways to pay much less taxes than that or not to pay them at all.

Cash flow adjustment could be used for any adjustment the investor deems necessary. Most commonly we use this field to account for stock options-related effects in excess of what is reported on the company's income statement. The cash flow adjustment is expressed as a percentage of the revenue, and in the current valuation of the XYL stock is equal to 0%.

Production assets are the company's assets used for manufacturing products or provision of services. In the valuation model input table they are expressed as a percentage of revenue and for XYL are equal to 35.7%.

Life of production assets of 22.9 years is the average useful life of capital assets used in Xylem operations. It is used to calculate yearly capital expenditures needed to keep these assets in good order - we call it the maintenance CAPEX.

Working capital is the difference between the company's current assets and liabilities. In the model we use the ratio of working capital to revenue, which for XYL is equal to 14.7%. A negative number means that the company is apt at using financial resources of its suppliers and customers; a large positive number, on the other hand, means that it either provides in-kind financing to others or is not good at managing its inventories.

Book value of equity - $2190 million for Xylem - is used in calculation of the "floor" for intrinsic valuation based on the discounted cash flow (DCF) method. Even if the prospects are very bad for a company, its assets could always be sold now for their current fair market value.

Shares outstanding of 180.804 million for Xylem is needed to calculate the intrinsic value of one share.

Market capitalization is used here only for reference purposes and as a quick check that the share price and the number of shares outstanding numbers are correct - something especially to be cognizant about at stock splits. So, the market capitalization of Xylem at the current share price and the inputted number of shares is $9.3 billion.


Premium access subscription - $499/yr

please register and log in before paying
RELATED COMPANIES Price Int.Val. Rating
FLS Flowserve 50.87 24.29  sell
GRC Gorman-Rupp 28.62 9.30  str.sell
IEX IDEX 104.76 45.16  str.sell
GGG Graco Inc. 107.85 60.09  sell
FELE Franklin Elect 41.10 33.50  sell
CFX Colfax 40.47 30.97  sell

COMPANY NEWS

▶ Xylem to host its 2017 Investor and Analyst Day   [Mar-31-17 10:10AM  Business Wire]
▶ Five ways to bet on water -Barron's   [Mar-19-17 02:50PM  Reuters]
▶ [$$] 5 Ways to Invest in Water   [Mar-18-17 01:21AM  at Barrons.com]
▶ Six months after $1.7B Sensus buy, Xylem CEO talks integration   [Feb-07-17 11:04AM  at bizjournals.com]
▶ Hedge Funds Are Buying Autoliv Inc. (ALV)   [Dec-09-16 04:44AM  at Insider Monkey]
▶ Is Xylem Inc (XYL) A Good Stock To Buy?   [Dec-08-16 08:51AM  at Insider Monkey]
▶ Xylem Volunteering to Solve Water Issues (XYL)   [Nov-28-16 02:55PM  at Investopedia]
▶ Xylem Inc. to Present at Baird 2016 Industrial Conference   [Oct-26-16 09:00AM  Business Wire]
▶ Xylem Inc. declares Q4 dividend of 15.49 cents per share   [Oct-13-16 04:36PM  Business Wire]
▶ Xylem Inc. declares Q3 dividend of 15.49 cents per share   [Aug-17-16 05:19PM  Business Wire]
▶ Business Watch   [12:29AM  at The Wall Street Journal]
Stock chart of XYL Financial statements of XYL
Valuation of Stocks

The paper VALUATION OF STOCKS: The Quest for Intrinsic Value provides a detailed description of our valuation model and discloses the calculation algorithm.

FREE DOWNLOAD
Follow us on:   twitter   twitter   twitter   twitter

VALUATION THEORY       ASSET ALLOCATION

About X-FIN       Site news       Privacy policy       Terms of use       FAQ

Copyright © X-FIN.com 2005-2017. All rigths reserved.